Tamer Khayal
Net worth: 1 M $ as of 31/05/2026
Net worth: 1 M $ as of 31/05/2026
Tamer I.
Khayal is Chief Medical Officer at TransMedics, Inc. since 2013 and Senior Vice President-International at TransMedics Group, Inc. starting in 2026.
Formerly, Dr. Khayal was Director-Clinical Affairs at Zentiva Group.
Education includes a doctorate from KasrAlAiny School of Medicine conferred in 1993.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 31/03/2026 | 15,038 ( 0.04% ) | 1 M $ | 31/05/2026 |
| Companies | Position | Start |
|---|---|---|
| TRANSMEDICS GROUP, INC. | Corporate Officer/Principal | 01/01/2018 |
TransMedics, Inc.
TransMedics, Inc. Medical SpecialtiesHealth Technology Manufactures and develops medical devices | Chief Tech/Sci/R&D Officer | 01/05/2001 |
| Companies | Position | End |
|---|---|---|
Zentiva Group as
Zentiva Group as Pharmaceuticals: MajorHealth Technology Manufactures, develops and markets generics & pharmaceutical products | Chief Tech/Sci/R&D Officer | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 4 |
|---|---|
Zentiva Group as
Zentiva Group as Pharmaceuticals: MajorHealth Technology Manufactures, develops and markets generics & pharmaceutical products | Health Technology |
TransMedics, Inc.
TransMedics, Inc. Medical SpecialtiesHealth Technology Manufactures and develops medical devices | Health Technology |
KasrAlAiny School of Medicine
KasrAlAiny School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TransMedics Group, Inc.
TransMedics Group, Inc. Medical SpecialtiesHealth Technology Manufactures portable electromechanical medical devices for organ transplantation of end-stage organ failure patients | Health Technology |
Select your edition
All financial news and data tailored to specific country editions